Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China. - Wang J; Du J; Liu Y; Xu Y; Han J; Zhang X (Vaccines, 2024)